UTSI Q4 2019 Earnings Significant EPS Miss Highlights Persistent Headwinds Caleres CAL Q1 2026 Earnings EPS Beat Helps Narrow Loss Stock Gains 38 PharmaCyte Biotech PMCB Q1 2026 Earnings Narrowing Loss Amid Strategic Pipeline Progress NNDM Q1 2026 Earnings Loss Per Share of 034 as Stock Rises Amid Strategic Progress KREF Q1 2026 Earnings Deep EPS Miss Masks Underlying Stability Littelfuse LFUS Q1 2026 Earnings EPS Beats Estimates by 1406 Shares Gain